Patents by Inventor Robert A. Mastico

Robert A. Mastico has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220378694
    Abstract: Methods of administering immunoconjugates that bind to FOLR1 are provided. The methods comprise administering an anti-FOLR1 immunoconjugate to a person in need thereof, for example, a cancer patient, at a therapeutically effective dosing regimen that results in minimal adverse effects.
    Type: Application
    Filed: April 14, 2022
    Publication date: December 1, 2022
    Applicant: ImmunoGen, Inc.
    Inventors: Kelli Running, Robert A. Mastico, James J. O'Leary, Olga AB, Beni Wolf
  • Publication number: 20200046634
    Abstract: Methods of administering immunoconjugates that bind to FOLR1 are provided. The methods comprise administering an anti-FOLR1 immunoconjugate to a person in need thereof, for example, a cancer patient, at a therapeutically effective dosing regimen that results in minimal adverse effects.
    Type: Application
    Filed: April 19, 2019
    Publication date: February 13, 2020
    Applicant: ImmunoGen, Inc.
    Inventors: Kelli RUNNING, Robert A. MASTICO, James J. O'LEARY, Olga AB, Beni WOLF
  • Publication number: 20170239367
    Abstract: Methods of administering immunoconjugates that bind to FOLR1 are provided. The methods comprise administering an anti-FOLR1 immunoconjugate to a person in need thereof, for example, a cancer patient, at a therapeutically effective dosing regimen that results in minimal adverse effects.
    Type: Application
    Filed: December 22, 2016
    Publication date: August 24, 2017
    Inventors: Kelli RUNNING, Robert A. Mastico, James J. O'Leary, Olga Ab, Beni Wolf
  • Publication number: 20140363451
    Abstract: Methods of administering immunoconjugates that bind to FOLR1 are provided. The methods comprise administering an anti-FOLR1 immunoconjugate to a person in need thereof, for example, a cancer patient, at a therapeutically effective dosing regimen that results in minimal adverse effects.
    Type: Application
    Filed: May 13, 2014
    Publication date: December 11, 2014
    Applicant: ImmunoGen, Inc.
    Inventors: Kelli RUNNING, Robert A. Mastico, James J. O'Leary, Olga Ab, Beni Wolf
  • Patent number: 5534257
    Abstract: A chimaeric protein, suitable for incorporation in a vaccine and capable of forming parts of a capsid assembly, comprises the amino acid sequence of the coat protein of phage MS-2, or a conservatively modified variant thereof, or sufficient of said sequence or variant to retain capsid-forming capability, which amino acid sequence has been modified by insertion of a foreign epitope in the region corresponding to a protuberant protein hairpin in the capsid assembly as shown in the crystal structure of the intact phage.
    Type: Grant
    Filed: November 8, 1993
    Date of Patent: July 9, 1996
    Assignee: British Technology Group Limited
    Inventors: Robert A. Mastico, Peter G. Stockley, Simon J. Talbot
  • Patent number: 5450015
    Abstract: An impedance measurement system including a series circuit having a reference impedance leg and a measurement leg, the measurement leg including first and second spaced apart electrodes defining a region for receiving a sample of material to be tested; an oscillator circuit connected in parallel with the series circuit and providing a reference voltage and a signal voltage proportioned to the impedance of the measurement leg; and a detector circuit producing an output voltage proportional to changes between the reference voltage and the signal voltage.
    Type: Grant
    Filed: February 24, 1994
    Date of Patent: September 12, 1995
    Assignee: Forte Technology, Inc.
    Inventors: Robert A. Mastico, Robert R. Moline